IP Library Granted Patent US 10,137,037
Granted Patent B2
US 10,137,037 · App. 13/674,804 · Granted Nov 27, 2018

Reduced-pressure, tunnel-wound dressings, systems, and methods

Inventors: Aidan Marcus Tout (Alderbury, GB); Richard Daniel John Coulthard (Verwood, GB); Christopher Brian Locke (Bournemouth, GB); Timothy Mark Robinson (Basingstoke, GB)
Assignee: KCI Licensing, Inc.
A61F13/00068A61M1/0023A61M1/0088A61F2013/0054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,137,037
App. No.
13/674,804
Granted
Nov 27, 2018
Kind
B2
Abstract

Systems, methods, and dressing are presented for treating a tunnel wound on a patient. In one instance, a reduced-pressure, tunnel-wound dressing includes a longitudinal core member formed from a closed-cell foam that is surrounded by a first longitudinal concentric member formed from a manifolding material. When subjected to reduced pressure, the longitudinal core member expands and the first longitudinal concentric member compresses. These actions create intimate contact between the tunnel wound and the dressing, oppose collapse of the tunnel, and when reduced pressure is removed provide clearance to remove the dressing. Other embodiments are presented.

Claims (13)

1. A method to treat a tunnel wound or fistula, the method comprising:

providing a dressing, wherein the dressing comprises:

a distal end, a proximal end, and a longitudinal profile between the distal end and the proximal end, wherein a length of the dressing between the distal end and the proximal end is greater than a width of the dressing,

a longitudinal core member formed from a closed-cell foam and configured to expand under reduced pressure, and

a first longitudinal concentric member formed from an open-cell foam, wherein the first longitudinal concentric member is concentrically disposed on a circumference of the longitudinal core member;

inserting the distal end of the dressing into the tunnel wound or the fistula such that the distal end is positioned proximate to a bottom of the tunnel wound or the fistula and the proximal end of the dressing is positioned proximate to an opening of the tunnel wound or the fistula, wherein a gap is formed between the dressing and an inner wall of the tunnel wound or the fistula;

delivering the reduced pressure to the dressing to expand the longitudinal core member and to cause an outer circumference of the dressing to contact the inner wall of the tunnel wound or the fistula, wherein the first longitudinal concentric member compresses upon contact with the inner wall of the tunnel wound or the fistula; and

removing the reduced pressure to retract the dressing away from the inner wall of the tunnel wound or the fistula.

2. The method of claim 1 , wherein the dressing further comprises a second longitudinal concentric member formed from a non-adherent material having a plurality of apertures, and wherein the second longitudinal concentric member is concentrically disposed on a circumference of the first longitudinal concentric member.

3. The method of claim 1 , wherein a diameter of the longitudinal core member expands at least 10 percent and a diameter of the first longitudinal concentric member compresses at least 10 percent when the reduced pressure is applied to the dressing.

4. The method of claim 1 , further comprising introducing a liquid into the dressing.

5. The method of claim 1 , wherein removing the reduced pressure comprises removing the reduced pressure in two or more stages.

6. The method of claim 1 , wherein the longitudinal core member and the first longitudinal concentric member comprise bioresorbable materials, and wherein the method further comprises allowing the dressing to remain in the tunnel wound until the dressing dissolves.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2013
From: TOUT, AIDAN MARCUS; COULTHARD, RICHARD DANIEL JOHN; LOCKE, CHRISTOPHER BRIAN; ROBINSON, TIMOTHY MARK
To: KCI LICENSING, INC.
Reel/Frame 030769/0570 →
Continuity (2)
Provisional Application 61558642 · Nov 11, 2011
Related Publication 20130123723A1 · May 16, 2013